rdf:type |
|
lifeskim:mentions |
umls-concept:C0022885,
umls-concept:C0030472,
umls-concept:C0030705,
umls-concept:C0205265,
umls-concept:C0205436,
umls-concept:C0220825,
umls-concept:C0220912,
umls-concept:C0220913,
umls-concept:C0250314,
umls-concept:C0282451,
umls-concept:C0441792,
umls-concept:C0684249,
umls-concept:C1457887,
umls-concept:C1555582
|
pubmed:issue |
3 Suppl
|
pubmed:dateCreated |
2007-9-17
|
pubmed:abstractText |
This chapter of the guidelines is intended to provide an evidence-based assessment of the initial evaluation of patients recognized as having lung cancer and the recognition of paraneoplastic syndromes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0012-3692
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
132
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
149S-160S
|
pubmed:meshHeading |
|
pubmed:year |
2007
|
pubmed:articleTitle |
Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition).
|
pubmed:affiliation |
Department of Respiratory Medicine, University College Hospital, Grafton Way, London WC1E 6AU, UK. stephen.spiro@uclh.nhs.uk
|
pubmed:publicationType |
Journal Article,
Practice Guideline
|